Introduction ▼
Conventional ultrasound is the first-line imaging method for investigating biliary diseases. Once bile duct obstruction is detected, it is necessary to determine both the stop level and its nature. Baseline sonography may be able to localize the intraor extrahepatic origin of cholestasis but, in general, has a relatively low accuracy for this purpose [1, 2] . As a consequence, in many cases it is necessary to combine ultrasound (US) with other noninvasive methods, including computed tomography (CT) or magnetic resonance (MR), or invasive imaging techniques, including endoscopic retrograde cholangiopancreatography (ERCP) or echo-endoscopy, to get the final diagnosis. Development of new sonographic contrast media and improvements in detection techniques with low acoustic power have represented significant advances in ultrasound diagnosis. Second-generation ultrasound contrast agents include gas microbubble-based substances, stabilized by a noma n = 4, gallbladder carcinoma n = 2, ampullary carcinoma n = 1 and lymphoma n = 1) and 17 benign lesions (lithiasis or biliary sludge n = 15, xanthogranulomatous cholecystitis n = 1 and indeterminate n = 1). CEUS accuracy compared with final diagnoses based on combined reference standard was 86.4 %. CEUS correctly identified 36 of 42 malignant lesions (sensibility 85.7 %) and 15 of 17 benign lesions (specificity 88.2 %). The positive predictive value of CEUS for malignancy was 94.7 %, while the negative predictive value was 71.4 %. Conclusion: CEUS is useful to differentiate between benign and malignant causes of obstructive jaundice. This technique improves the detection of bile duct invasion in hepatic neoplasms and permits better evaluation of intra-and extraductal extension of hilar hepatobiliary tumors. new EFSUMB guidelines for non-hepatic use in 2008. A more recent update (2011) has recognized the usefulness of CEUS for the diagnosis of biliary diseases [6] . There are few studies in the literature exploring the benefits of CEUS in biliary diseases [7] [8] [9] . Moreover, all of them evaluate its use in gallbladder and biliary duct disease from a general point of view, but do not investigate its diagnostic value in biliary duct obstruction. The aim of this study was to determine the usefulness of CEUS to differentiate among benign and malignant biliary duct obstruction.
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Materials and Methods
▼
Study population
Between November 2006 and December 2013, 59 patients (33 men and 26 women) underwent biliary CEUS under the following requisites: 1. intrahepatic (duct diameter > 40 % above that of the adjacent portal vein) or extrahepatic ( > 7 mm) bile duct dilatation demonstrated by baseline ultrasound in a patient with clinical findings of obstructive jaundice, 2. Unknown cause of biliary duct obstruction. Patients were excluded if the diagnosis was straightforward after baseline ultrasound, as in cases of lithiasis with acoustic shadow or masses in the pancreatic head. We also excluded patients with known severe cardiopathy and pregnant or lactating women. The study fulfilled the ethical rules of our institution. In our unit, contrast-enhanced ultrasound is routinely indicated in the case of a suspected neoplastic lesion. Considering that the study protocol did not require any further invasive maneuvers, we did not request formal approval by the local ethical committee of our center. Patients were specifically informed of the nature and conditions of the ongoing study and verbal informed consent was requested and obtained in all cases. We used the histologic reports from samples obtained by ERCP or surgery as the reference diagnosis. When these were not available, we used clinical and radiologic follow-up data provided by CT, MRI or ERCP. Lesions were classified as benign, malignant or indeterminate, according to these results.
Ultrasound technique
All ultrasound examinations were performed by the same radiologist with more than 8 years of CEUS experience. In all studies baseline US examinations were the first approach. After confirmation of bile duct obstruction, a bolus of 2.5 ml of Sonovue ® (Bracco, Milan, Italy), composed by sulfur hexafluoride microbubbles with a phospholipid shell, was injected through the antecubital vein, and CEUS study was performed in real time along 5', with a low acoustic power contrast-specific imaging technique. A simultaneous display of tissue and contrast signals ensured visualization of the dynamic enhancement and washout patterns. Relevant images and videos were recorded digitally.
Data analysis
Images were interpreted initially by a single radiologist, with more than 8 years of CEUS experience, who was not aware of the results of the other imaging test. Subsequently, an interpretative consensus was reached by all authors after revisiting images and videos. Basal ultrasound was analyzed and then compared with relevant CEUS findings. Pathologic and imaging studies were recorded in a database, and the same applied for the anatomic locations of the lesions in the biliary tree (intrahepatic, hilar, common hepatic duct, common biliary duct and intrapancreatic duct). Sensitivity was calculated as the fraction of true positives over the number of true positives plus false negatives, i. e., the total number of malignant lesions, as demonstrated by the combined reference standard. Specificity was calculated as the fraction of true negatives over the number of true negatives plus false positives. Diagnostic accuracy was defined by the number of true positives plus true negatives divided by the total number of patients. Positive predictive value was calculated by dividing the true positives by the total positive results in CEUS. Negative predictive value was calculated by dividing the true negatives by the total negative results in CEUS.
Results
▼
CEUS was performed in 59 patients (33 men and 26 women, with a mean age of 71.5 years (range 48-90)). The final diagnoses included 42 malignant and 17 benign lesions. A histologic analysis was possible in 28 patients (47.5 %), while the diagnosis was based on data from the clinical and radiological follow-up in the remaining 31 cases (52.5 %) ( • ▶ Table 1 ). • ▶ Table 2 shows the final diagnoses. Among malignancies, the most frequent diagnosis was cholangiocarcinoma (22 patients). In 6 cases of hilar cholangiocarcinoma, baseline ultrasound disclosed intrahepatic bile duct dilatation with possible hilar lesions, isoechoic to liver parenchyma. CEUS demonstrated in all cases infiltrating enhancing lesions in the biliary confluence with later washout and discrete margins ( • ▶ Fig. 1 ).
Extrahepatic cholangiocarcinoma presented as common hepatic duct lesions in 7 cases and common biliary duct lesions in 9 cases; all but one of these cases showed focal parietal thickening or intraductal lesions of variable echogenicity. CEUS demonstrated hyperenhancement and posterior washout in intraductal lesions, pointing to its tumoral nature ( • ▶ Fig. 2, 3) . In one case CEUS showed a hypoechoic non-enhancing completely necrotic mass with portal malignant thrombosis ( • ▶ Fig. 4 ). Fig. 5 ).
6 cases corresponded to bile duct metastases from gastric carcinoma (n = 3), colonic carcinoma (n = 2) and renal carcinoma (n = 1). In 4 cases CEUS demonstrated intraductal lesions in the hilar confluence and extrahepatic biliary ducts, while bile duct infiltration by contiguous liver malignancy was observed in the remaining 2 cases ( • ▶ Fig. 6 ). Fig. 7) . One case of cholangitis showed diffuse hyperenhancement in the duct wall during the arterial phase and wash-out in the portal and late phase. In another case, baseline ultrasound demonstrated ductal dilatation secondary to a heterogeneous hilar mass, with calcification, extending to the gallbladder and engulfing biliary ducts and vessels. CEUS showed intense enhancement in the arterial phase, with posterior washout. Pathological study disclosed infiltrative xanthogranulomatous cholecystitis ( • ▶ Fig. 8 ).
We also studied 7 patients with suspected biliary prosthesis obstruction. CEUS showed no enhancement in 5 cases ( • ▶ Fig. 7) , which came out to be sludge, and enhancement in 2 other cases corresponding to cholangiocarcinoma relapse and metastasic hypernephroma. In 6 cases the results of CEUS were indeterminate. In 4 of these cases, lesions affected the intrapancreatic distal common biliary duct. The location of the lesions in the biliary tree is reflected between intra-and extrahepatic cholestasis. However, this technique offers a low sensitivity at the time of establishing the nature of the lesion. In the present study, we have demonstrated that CEUS improves diagnosis, differentiating benign from malignant lesions in the majority of cases. We believe that CEUS represents an appropriate first-line diagnostic procedure following initial identification of a biliary obstruction by non-enhanced ultrasound allowing segregation of patients who require CT or MR for staging and surgical planning from those who can proceed directly to ERCP. Performing CEUS during the same session can save time and is financially prudent.
The comparison of CEUS and contrast-enhanced cross-sectional imaging is sometimes problematic. CEUS offers real-time dynamic study without gaps in data acquisition, while CT and MR have scan delays and, consequently, may miss the early initial enhancement in the arterial phase. Moreover, the use of a purely intravascular contrast medium can avoid some problematic effects happening with the interstitial diffusion in MR and CT contrast agents, such as masquerading of some lesions during the portal and late phase produced by the persistent enhancement [10] . Alternatively the lack of interstitial enhancement in CEUS can theoretically limit differentiation between neoplastic processes with or without an important interstitial component. In CEUS images, intrahepatic bile duct dilation is more conspicuous, due to parenchymal enhancement, improving the detection of intraluminal lesions, whether malignant or corresponding to sludge or biliary stones. In patients with neoplastic jaundice, ascertaining exactly the cause, level and extension of the lesion is necessary, in order to select candidates for surgical resection. Similarly to CT and MR, CEUS allows a more precise determination of neoplasic parenchymatous extension in tumors of ductal origin, as also ductal extension of lesions originated in the liver parenchyma.
Cholangiocarcinoma is the most frequent biliary neoplasm, classified as intrahepatic (peripheral and hilar) or extrahepatic. Hilar cholangiocarcinoma originates in the bile duct bifurcation, and tends to infiltrate the adjacent liver parenchyma. Basal ultrasound shows intrahepatic dilatation with a normal extrahepatic duct, but has a low capacity to establish the nature of the obstruction, due to the frequent isoechogenicity of these lesions with normal liver parenchyma and its infiltrative nature [7] [8] [9] . In our experience, Klatskin tumors show a variable enhancement in early phases with a constant washout in late phases which nicely delineates the limits of the lesion. These features are consistent with those described in the literature. Xu et al. [11] studied the dynamic behavior of hilar cholangiocarcinoma in CEUS, demonstrating hyperenhancement, isoenhancement and hypoenhancement in the arterial phase in 43. 8 [7, 10, 12] . Bile duct infiltration is a rare complication of hepatocellular carcinomas and can present with contiguous direct invasion or embolization of an occult parenchymatous lesion [9] . Both presentations were observed in this study, with an enhancement pattern similar to the original tumor, hyperenhancement in the arterial phase and contrast wash-out in the late phase [13] . CEUS is also useful to categorize intrabiliary metastasic lesions of a non-hepatic origin. These are infrequent lesions with a difficult differential diagnosis with malignant primary lesions. They can present as fully intraductal lesions or as secondary invasive lesions from adjacent liver metastases. Different primary tumors can cause biliary metastatic obstruction but gastrointestinal malignancies, particularly colonic cancer, are most frequent [9] . In our study, gastric cancer was most common. CEUS improves the detection of pancreatic head tumors not detected by basal ultrasound. The pancreas enhances homogeneously in the arterial phase and presents a transient venous phase, facilitating detection of carcinoma, which presents typically with hypoenhancement in all phases [6] . Fan et al. [14] reported a sensitivity, specificity and accuracy of 91.7, 97.2 and 87 %, respectively, at the time of detection of pancreatic adenocarcinomas with CEUS. The results are similar to those obtained with contrast-enhanced CT.
Benign lesions show no enhancement on CEUS, due to the inert nature of intraductal contents (biliary sludge, lithiasis, blood clots or detritus), allowing differentiation from tumoral casts in most cases.
Even if no enhancement is the rule in benign lesions, there are exceptions, which include inflammatory conditions such as xanthogranulomatous lesions or the faint captation of the ductal wall in cases of cholangitis. These examples emphasize that enhancement is not synonymous with malignant lesion. Alternatively, extensive necrotic malignant lesions can present without contrast enhancement in rare instances. CEUS shares some limitations with basal ultrasound, including operator dependence. Obesity and bowel gas are important obstacles in some cases, particularly during the evaluation of the distal bile duct. This limitation was behind most indeterminate cases in this study. Important limitations of the study are its retrospective design and the absence of a unitary reference test, due to the impossibility of obtaining a pathologic diagnosis in some cases. In the latter cases we used CT, MR and follow-up to set a reference diagnosis. Prospective studies are necessary to validate our conclusions, as are comparative investigations about agreement among CEUS, on one side, and CT or MR, on the other.
Conclusion ▼
CEUS is useful to differentiate the benign or malignant nature of a biliary duct obstruction. It may offer a combined approach with CT and MR, saving the indication of these techniques in unequivocal cases of benignity and represents an alternative in those cases in which these techniques are hazardous or contraindicated, including instances of contrast allergy or kidney failure. In addition, CEUS is able to disclose tumoral invasion of biliary ducts by liver tumors and helps to define the local extension of hilar hepatobiliary neoplasms.
